# CD1E

## Overview
CD1E is a gene that encodes the CD1e protein, a member of the CD1 family of glycoproteins involved in lipid antigen processing. Unlike other CD1 proteins that present antigens on the cell surface, CD1e functions intracellularly as a lipid chaperone within lysosomes, facilitating the breakdown and remodeling of complex glycolipids into simpler forms for presentation by other CD1 molecules (Zajonc2024Architecture; Adams2014Lipid). The CD1e protein is structurally similar to MHC class I molecules, comprising a heavy chain that associates with β2-microglobulin and includes α1, α2, and α3 domains, with the α1 and α2 domains forming the antigen-binding cleft (Reinink2016Mammalian). This protein is primarily expressed in dendritic cells and undergoes post-translational modifications such as glycosylation, which is common among CD1 family members (Zajonc2024Architecture). CD1e's role in lipid antigen processing is crucial for immune surveillance and response, although its direct involvement in disease susceptibility, such as in Guillain-Barré Syndrome, remains to be fully elucidated (Kuijf2008Susceptibility).

## Structure
The CD1E protein is a member of the CD1 family of glycoproteins involved in lipid antigen presentation. It is expressed as several alternatively spliced isoforms in dendritic cells, which suggests functional diversity (Zajonc2024Architecture). The protein is composed of a heavy chain that forms a complex with β2-microglobulin, resembling the structure of MHC class I molecules (Reinink2016Mammalian). The heavy chain includes α1, α2, and α3 domains, with the α1 and α2 domains forming the antigen-binding cleft (Reinink2016Mammalian). 

CD1E is involved in intracellular lipid processing rather than surface presentation, acting as a lipid chaperone within lysosomes. It facilitates the processing of complex glycolipids, such as phosphatidylinositol hexamannosides, into simpler forms that can be presented by other CD1 proteins (Zajonc2024Architecture). Unlike other CD1 isotypes, CD1E does not display lipids at the cell surface but instead activates enzymes like α-mannosidases for glycolipid processing (Zajonc2024Architecture). 

The protein undergoes post-translational modifications, including glycosylation, which is common among CD1 family members (Zajonc2024Architecture). The molecular structure of CD1E has not been fully determined, and specific details on its primary, secondary, tertiary, or quaternary structures are not available (Reinink2016Mammalian).

## Function
CD1E is a gene that encodes the CD1e protein, which plays a crucial role in the presentation of lipid and glycolipid antigens to T cells. Unlike other CD1 isoforms, CD1e does not directly present antigens to T cells. Instead, it functions as a lipid chaperone, facilitating the processing and loading of lipid antigens onto other CD1 molecules within the endosomal compartments of antigen-presenting cells (Brigl2004CD1:; Adams2014Lipid). This activity is essential for the proper functioning of the immune system, as it aids in the presentation of lipid antigens to T cells, thereby contributing to immune surveillance and response.

CD1e is primarily active in the endosomal compartments, where it assists in the breakdown and remodeling of complex lipids, making them suitable for presentation by other CD1 molecules. This process is vital for the activation of T cells that recognize lipid antigens, which are important in both innate and adaptive immune responses (Brigl2004CD1:). The role of CD1e in healthy human cells is primarily supportive, ensuring that lipid antigens are effectively processed and presented, thus maintaining immune homeostasis and facilitating responses to pathogens.

## Clinical Significance
Mutations and alterations in the CD1E gene have been investigated for their potential role in autoimmune diseases, particularly Guillain-Barré Syndrome (GBS). CD1E is involved in the processing and presentation of lipid antigens, which is crucial for immune system function. Although some studies have suggested that single nucleotide polymorphisms (SNPs) in CD1E might influence susceptibility to GBS, larger cohort studies have not consistently supported this association (Kuijf2008Susceptibility). 

Research in different populations, such as the Bangladeshi cohort, also found no significant association between CD1E polymorphisms and GBS susceptibility, although certain haplotypes like CD1A*01/CD1E*01 were linked to an increased risk of developing the disease (Rahman2018CD1A). Despite these findings, the role of CD1E in GBS remains inconclusive, and further research is needed to clarify its clinical significance (Kuijf2008Susceptibility).

Overall, while CD1E mutations may affect antigen presentation, their direct impact on disease susceptibility, particularly in GBS, has not been definitively established, highlighting the complexity of genetic factors in autoimmune conditions (Kuijf2008Susceptibility).

## Interactions
The CD1e protein is involved in several interactions within the endosomal/lysosomal system, primarily related to its role in lipid antigen processing. A significant interaction is with the lysosomal-associated transmembrane protein 5 (LAPTM5). CD1e and LAPTM5 colocalize in the trans-Golgi network and late endosomal compartments, and their association is enhanced in the presence of bafilomycin, an inhibitor of vacuolar ATPase that prevents endosomal acidification. This interaction is confirmed through co-immunoprecipitation and Förster Resonance Energy Transfer/Fluorescence Lifetime Imaging Microscopy (FRET/FLIM) experiments, indicating a close proximity between the two proteins (Angénieux2012LysosomalAssociated).

Despite the physical interaction, LAPTM5 does not significantly influence the ubiquitination or the generation of the soluble form of CD1e, suggesting that while LAPTM5 is a molecular partner, it does not control CD1e's maturation process (Angénieux2012LysosomalAssociated). The interaction between CD1e and LAPTM5 is considered physiological, occurring naturally in M10 cells, and is not solely induced by experimental treatments (Angénieux2012LysosomalAssociated). There is no evidence from the provided context that CD1e interacts with nucleic acids.


## References


[1. (Kuijf2008Susceptibility) Mark L. Kuijf, Karin Geleijns, Noureddine Ennaji, Wouter van Rijs, Pieter A. van Doorn, and Bart C. Jacobs. Susceptibility to guillain–barré syndrome is not associated with cd1a and cd1e gene polymorphisms. Journal of Neuroimmunology, 205(1–2):110–112, December 2008. URL: http://dx.doi.org/10.1016/j.jneuroim.2008.08.013, doi:10.1016/j.jneuroim.2008.08.013. This article has 27 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.jneuroim.2008.08.013)

[2. (Reinink2016Mammalian) Peter Reinink and Ildiko Van Rhijn. Mammalian cd1 and mr1 genes. Immunogenetics, 68(8):515–523, July 2016. URL: http://dx.doi.org/10.1007/s00251-016-0926-x, doi:10.1007/s00251-016-0926-x. This article has 30 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00251-016-0926-x)

[3. (Angénieux2012LysosomalAssociated) Catherine Angénieux, François Waharte, Alexandre Gidon, François Signorino-Gelo, Virginie Wurtz, Rim Hojeij, Fabienne Proamer, Christian Gachet, Alain Van Dorsselaer, Daniel Hanau, Jean Salamero, and Henri de la Salle. Lysosomal-associated transmembrane protein 5 (laptm5) is a molecular partner of cd1e. PLoS ONE, 7(8):e42634, August 2012. URL: http://dx.doi.org/10.1371/journal.pone.0042634, doi:10.1371/journal.pone.0042634. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0042634)

[4. (Brigl2004CD1:) Manfred Brigl and Michael B. Brenner. Cd1: antigen presentation and t cell function. Annual Review of Immunology, 22(1):817–890, April 2004. URL: http://dx.doi.org/10.1146/annurev.immunol.22.012703.104608, doi:10.1146/annurev.immunol.22.012703.104608. This article has 842 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1146/annurev.immunol.22.012703.104608)

[5. (Adams2014Lipid) Erin J Adams. Lipid presentation by human cd1 molecules and the diverse t cell populations that respond to them. Current Opinion in Immunology, 26:1–6, February 2014. URL: http://dx.doi.org/10.1016/j.coi.2013.09.005, doi:10.1016/j.coi.2013.09.005. This article has 39 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.coi.2013.09.005)

6. (Zajonc2024Architecture) Architecture of CD1 Proteins. This article has 12 citations.

[7. (Rahman2018CD1A) Mohammad I. Rahman, Iffat Jahan, Mir M. Khalid, Israt Jahan, Rijwan U. Ahammad, Shamsun Nahar, and Zhahirul Islam. Cd1a and cd1e gene polymorphisms are not associated with susceptibility to guillain-barré syndrome in the bangladeshi population. Journal of Neuroimmunology, 314:8–12, January 2018. URL: http://dx.doi.org/10.1016/j.jneuroim.2017.11.013, doi:10.1016/j.jneuroim.2017.11.013. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.jneuroim.2017.11.013)